a biosimilar version of the insulin blockbuster Lantus launched today in the US. Basaglar will also undercut Sanofi’s longer lasting version, Toujeo, and is likely to win a large share of the ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.